|
RPL7L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.18420001266651E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.538100E-03 |
| Normal-vs-Stage2 |
1.56480000002013E-06 |
| Normal-vs-Stage3 |
2.37989961071605E-10 |
| Normal-vs-Stage4 |
1.53470003372291E-09 |
| Stage1-vs-Stage2 |
2.570100E-02 |
| Stage1-vs-Stage3 |
1.438170E-03 |
| Stage1-vs-Stage4 |
1.736870E-03 |
| Stage2-vs-Stage3 |
5.941800E-01 |
| Stage2-vs-Stage4 |
5.350800E-01 |
| Stage3-vs-Stage4 |
9.248200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16839982133854E-10 |
| Normal-vs-AfricanAmerican |
4.318600E-01 |
| Normal-vs-Asian |
1.720820E-01 |
| Caucasian-vs-AfricanAmerican |
5.007600E-01 |
| Caucasian-vs-Asian |
4.365400E-01 |
| AfricanAmerican-vs-Asian |
9.876800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.27640000078E-08 |
| Normal-vs-Female |
1.81290000000889E-06 |
| Male-vs-Female |
1.881040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.638650E-03 |
| Normal-vs-Age(41-60Yrs) |
1.062930E-03 |
| Normal-vs-Age(61-80Yrs) |
1.43880019010112E-10 |
| Normal-vs-Age(81-100Yrs) |
8.846000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.696390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.185800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.508200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.362650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.082810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.864600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.435600E-01 |
| Normal-vs-Grade 2 |
2.14689999999962E-05 |
| Normal-vs-Grade 3 |
2.12799999999014E-05 |
| Normal-vs-Grade 4 |
1.45069511958695E-11 |
| Grade 1-vs-Grade 2 |
1.962040E-02 |
| Grade 1-vs-Grade 3 |
2.476700E-03 |
| Grade 1-vs-Grade 4 |
3.89109999999748E-05 |
| Grade 2-vs-Grade 3 |
1.495160E-01 |
| Grade 2-vs-Grade 4 |
7.51170000000689E-05 |
| Grade 3-vs-Grade 4 |
6.600500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.697530E-03 |
| Normal-vs-ccB subtype |
2.214500E-04 |
| ccA subtype-vs-ccB subtype |
5.332000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.421800E-04 |
| Normal-vs-N1 |
1.530400E-02 |
| N0-vs-N1 |
5.024000E-01 |
|
|
